Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
121 hedge funds and large institutions have $245M invested in Arena Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 19 closing their positions.
56% more call options, than puts
Call options by funds: $3.07M | Put options by funds: $1.97M
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
3% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 35
1% more funds holding
Funds holding: 120 → 121 (+1)
8% less capital invested
Capital invested by funds: $267M → $245M (-$21.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$17.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.91M |
| 3 |
Millennium Management
New York
|
+$2.68M |
| 4 |
Renaissance Technologies
New York
|
+$2.09M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
+$1.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.1M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$9.43M |
| 3 |
State Street
Boston,
Massachusetts
|
-$9.34M |
| 4 |
DM
Deerfield Management
New York
|
-$8.86M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.77M |
ARNA Hedge Fund Activity: Q4 2015 in Review
121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2015, worth a combined $245M — down 8.1% from $267M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new ARNA positions and 19 closed out — a net gain of 2 holders — while 36 added to existing stakes and 35 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $17.8M. The largest seller was Wellington Management Group, cutting an estimated $18.1M.
- 121 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2015, up from 120 in Q3 2015.
- Funds reported $245M of Arena Pharmaceuticals Inc stock for Q4 2015, down 8.1% quarter-over-quarter.
- 21 funds opened new Arena Pharmaceuticals Inc positions in Q4 2015 and 19 closed out, a net change of +2 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q4 2015 was RA Capital Management, an estimated $17.8M added.
- The largest Arena Pharmaceuticals Inc seller in Q4 2015 was Wellington Management Group, an estimated $18.1M sold.
Based on aggregated 13F filings for Q4 2015.